info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Predictive Disease Analytics Market Analysis

ID: MRFR//10332-HCR | 128 Pages | Author: Kinjoll Dey| December 2024

The global predictive disease analytics market is set to reach US$ 13.7 BN by 2032, at a 23.20% CAGR between years 2023-2032. The predictive disease analytics market stands at the nexus of healthcare and technology, amidst a vibrant environment constantly interacting with several key factors driving demand, innovation, and uptake. One of the major reasons is increasing prevalence rates for chronic diseases across the globe.
Although the prevalence of diseases like diabetes, cardiovascular ailments and cancer keeps on increasing so does the need for more elaborate technologies in predicting or preventing these illnesses. This demand provides the background for development and transformation of predictive disease analytics market. Technological progress is arguably a pillar of market dynamics.
The continuing advancements in data analytics, artificial intelligence and machine learning play a vital role to perfect the predictive disease analytics solutions. The market reacts with sophisticated tools able to not only forecast disease trends but also provide actionable personal insights and refine healthcare interventions. These innovations also help to develop a competitive environment in which companies seek ways for leading technological capacity.
Regulatory factors are an integral part of market dynamics. Hospitals operate under tough regulation to ensure patient safety, data privacy and ethical use of predictive analytics. Regulatory compliance then helps to shape the strategy of market participants. The strong regulatory structure increases the reliability of predictable disease analytics solutions, leading to confidence in healthcare infrastructure.
The market dynamics are influenced by economic factors such as healthcare expenditure and reimbursement policies. Predictive disease analytics solutions cost-effectiveness is the main factor that should be considered for adoption. Market participants steer these economic factors by creating deliverables that do not just aim to enhance patient outcomes but also provide efficiency gains while being instrumental in cost reduction for healthcare delivery.
The dynamics of the predictive disease analytics market are further attracted from globalization and collaborative efforts in healthcare. International research, development and data-sharing partnerships serve to create an interdependent global market where insights or solutions are not limited by geography. This globalization improves the expertise sharing that increases availability of predictive disease analytics solutions and leads to a homogenized approach towards provision.
Demographic changes, especially the aging population, play a critical role in market dynamics. Considering the increasing cases of age-related diseases, there is a high demand for predictive analytics that would help in fine tuning health care interventions to certain population groups. The market in turn provides solutions that provide the specific needs of older population and other special health situations.

Covered Aspects:

Report Attribute/Metric Details
Segment Outlook Component, Deployment, End User, and Region

Global Predictive Disease Analytics Market Overview


The Predictive Disease Analytics Market Size was valued at USD 2.1 Billion in 2022 and is projected to grow from USD 2.6 Billion in 2023 to USD 13.7 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 23.20% during the forecast period (2023 - 2032). Increased demand to reduce healthcare costs by eliminating wasteful expenses, the emergence of individualized and evidence-based therapy, and increased healthcare sector efficiency, are the key market drivers enhancing the market growth.


Predictive Disease Analytics Market Overview


Source: Secondary Research, Primary Research, MRFR Database and Analyst Review


Predictive Disease Analytics Market Trends



  • Increase in efficiency in the healthcare sector is driving the market growth


Increased healthcare sector efficiency, the emergence of personalized and evidence-based medicine, and the rise in demand to reduce wasteful spending on healthcare are the main reasons driving the market's expansion. However, the market's expansion is anticipated to be hampered by a lack of reliable infrastructure for optimal operation and a shortage of trained IT workers in the healthcare sector. Additionally, during the projected period, the increasing relevance of healthcare in emerging economies is anticipated to assist pave the way for new growth opportunities. The healthcare sector is facing difficulties such rising treatment costs, inadequate patient care, and low patient engagement and retention rates. As a result, the industry is adopting predictive disease analytics to optimize operations and give patients with better care. The healthcare predictive analytics sector is expanding for the most part due to these considerations. For instance, Hartford HealthCare and Google Cloud announced their long-term agreement in November 2022 to advance the digital transformation of their healthcare system in order to better data analytics and improve patient care.


The healthcare sector is rapidly becoming digitalized thanks to the quick development of technology and significant investment made by the sector. These analytical tools are being used all around the world to control patients' retention. The use of healthcare analytics also boosts employee productivity, enhances patient care, and lessens the stress on caregivers. To bring innovation in research and care, Databricks developed the Lakehouse paradigm for the healthcare and life science industries in March 2022. Analytics, data management, and cutting-edge AI for disease prediction, medical picture classification, and biomarker identification can all be done on one platform.


Predictive analytical tools are being more widely used in the healthcare sector due to a combination of rising government initiatives and rising financial investments in the area. For instance, in February 2023, the European Commission allocated USD 7.2 million for a new project that aims to create an AI-based platform for gathering and analyzing clinical data on novel oncology drugs in order to support regulators' and HTA agencies' evaluations of those drugs. Similar to this, the American government has launched a number of initiatives in this area, such as the HealthData.gov portal, which compiles data from a number of federal databases on subjects like clinical data, community health performance, and medical and scientific knowledge. In addition to hospitals, policymakers are using these platforms to analyze data and models in order to better decide which healthcare institutions should be funded and how to provide treatment for patients. Major market participants concentrate on creating technologically sophisticated instruments as well in order to increase their market dominance. Thus, driving the Predictive Disease Analytics market revenue.


Predictive Disease Analytics Market Segment Insights:


Predictive Disease Analytics Component Insights


The Market segments of Predictive Disease Analytics, based on Component, includes software & services and hardware. Software & services segment dominated the global market in 2022. Significant investments from the healthcare sector have been made in the IT sector due to the creation of platforms and the digitalization of data for analytics. The majority of firms outsource the data analytics aspect of their IT because they lack a data analytics division. As a result, there are more companies offering a wide range of services to organizations through data analytics. The growth of the industry is further boosted by expanding the services that data analytics offers.


Predictive Disease Analytics Deployment Insights


The Predictive Disease Analytics Market segmentation, based on Deployment, includes on-premise and cloud-based. On-premise segment dominated the global market in 2022. The ease of access and security are credited with the increase; most institutions are currently building tools and software to store data on-site, which is fueling category expansion. The present technologies are helpful for small organizations, but if the company manages a huge dataset, they may become difficult and time-consuming to employ when scaled up. For data security and storage, a large financial expenditure might be necessary.


Predictive Disease Analytics End User Insights


The Predictive Disease Analytics Market segmentation, based on End User, includes healthcare payers, healthcare providers, and other end users. Healthcare payers segment dominated the Predictive Disease Analytics Market in 2022. Insurance firms, corporations and unions who sponsor health plans, as well as governmental organizations and third-party payers, are examples of payers. Payers use predictive disease analytics systems for disease risk assessment, analyzing insurance claims before payment settlement, and preventing and identifying fraudulent claims. Payers utilize recent and previous data to forecast the future.


Figure 1: Predictive Disease Analytics Market, by End User, 2022 & 2032 (USD Billion)


Predictive Disease Analytics Market by End User


Source: Secondary Research, Primary Research, MRFR Database and Analyst Review


Predictive Disease Analytics Regional Insights


By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North America Predictive Disease Analytics Market dominated this market in 2022 (45.80%). The most cutting-edge medical facilities are located in the area, which accelerates platform adoption. The demand for hospitals and other businesses to embrace analytics tools has increased as a result of the growing burden of chronic diseases and the rising percentage of the elderly population. Further, the U.S. Predictive Disease Analytics market held the largest market share, and the Canada Predictive Disease Analytics market was the fastest growing market in the North America region.


Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.


Figure 2: PREDICTIVE DISEASE ANALYTICS MARKET SHARE BY REGION 2022 (USD Billion)


PREDICTIVE DISEASE ANALYTICS MARKET SHARE BY REGION


Source: Secondary Research, Primary Research, MRFR Database and Analyst Review


Europe Predictive Disease Analytics market accounted for the healthy market share in 2022. The geographical expansion is primarily caused by two factors: an increasing senior population and an increase in the prevalence of chronic diseases. Further, the German market of Predictive Disease Analytics held the largest market share, and the U.K market of Predictive Disease Analytics was the fastest growing market in the European region


The Asia Pacific Predictive Disease Analytics market is expected to register significant growth from 2023 to 2032. The market expansion is attributable to expanding supportive government programs. Additionally, the increase in healthcare spending spurs market expansion and creates new business prospects. Moreover, China’s market of Predictive Disease Analytics held the largest market share and the Indian market of Predictive Disease Analytics was the fastest growing market in the Asia-Pacific region.


Predictive Disease Analytics Key Market Players & Competitive Insights


Leading market players are investing heavily in research and development in order to expand their product lines, which will help the Predictive Disease Analytics market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their global footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Predictive Disease Analytics industry must offer cost-effective items.


Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the global Predictive Disease Analytics industry to benefit clients and increase the market sector. In recent years, the Predictive Disease Analytics industry has offered some of the most significant advantages to medicine. Major players in the Predictive Disease Analytics market, including Oracle, IBM, SAS, Allscripts Healthcare Solutions Inc., MedeAnalytics, Inc., Health Catalyst, and Apixio Inc., are attempting to increase market demand by investing in research and development Deployments.


Software development, licensing, and support are all services provided by Microsoft Corp. (Microsoft). The company provides a wide variety of operating systems, server applications, cross-device productivity tools, business solution tools, desktop and server administration tools, video games, and training and certification services. Additionally, it creates, produces, and markets hardware items like PCs, tablets, game consoles, and other sophisticated gadgets. The company offers a wide range of services, such as consultancy, cloud-based solutions, and solution support. Through original equipment manufacturers, distributors, resellers, online marketplaces, Microsoft stores, and other partner channels, Microsoft promotes, distributes, and sells its products. The company has operations throughout the Middle East, Africa, the Americas, Europe, and Asia-Pacific. The US city of Redmond, Washington, is where Microsoft is based. Microsoft introduced Microsoft Cloud for Healthcare in September 2020. This partnership between patients and providers will help in providing improved patient care insights.


An operator of healthcare networks with a focus on communities, technology, and people is Ardent Health Services. Health systems with a number of hospitals and centers for life-saving technologies make up the company's subsidiaries and facilities, allowing patients to benefit from its distinctive combination of resources and established managerial know-how. SwitchPoint Ventures and Ardent Health Service joined together to establish an innovation lab in January 2023. The studio's main priorities will be creating and implementing data-driven solutions. Polaris, SwitchPoint's ground-breaking technology for precisely forecasting patient volume in any healthcare context, has also been adopted by Ardent.


Key Companies in the market of Predictive Disease Analytics include



  • Oracle

  • IBM

  • SAS

  • Allscripts Healthcare Solutions Inc.

  • MedeAnalytics, Inc.

  • Health Catalyst

  • Apixio Inc.


Predictive Disease Analytics Industry Developments


February 2023: The European Commission has committed USD 7.2 million to a new initiative that aims to create an AI-based platform for gathering and evaluating clinical data on novel oncology drugs in order to enable regulators' and HTA agencies' evaluation of these drugs.


June 2020: A platform for healthcare data analytics was launched by the NIH to gather patient information for COVID-19 meaningful insights. However, it is anticipated that difficulties with privacy, a lack of rules, and algorithm bias will impede industry expansion.


Predictive Disease Analytics Market Segmentation:


Predictive Disease Analytics Component Outlook



  • Software & Services

  • Hardware


Predictive Disease Analytics Deployment Outlook



  • On-premise

  • Cloud-based


Predictive Disease Analytics End User Outlook



  • Healthcare Payers

  • Healthcare Providers

  • Other End Users


Predictive Disease Analytics Regional Outlook



  • North America

    • US.

    • Canada



  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe



  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Australia

    • Rest of Asia-Pacific



  • Rest of the World

    • Middle East

    • Africa

    • Latin America



Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.